Arterial Network Interviews Global Health Leaders at WISH Summit: Maurizio Vecchione of Global Good and Mental Health Expert Paul Farmer

Recently, VCBeat (WeChat: vcbeat) was invited to attend the WISH Health Innovation Conference held in Doha, the capital of Qatar. The event provided not only an opportunity to experience the local culture and customs of this Middle Eastern oil-rich nation but also enabled participation in discussions on healthcare innovation led by top global speakers.

Our first interviewee is Maurizio Vecchione, Senior Vice President of Global Good. Global Good is a foundation established through a partnership between Intellectual Ventures (IV) and the Bill & Melinda Gates Foundation. Its primary mission is to incubate and support technology translation, including innovations in disease modeling, vaccine logistics, vector control, diagnostics for malaria and tuberculosis, and agriculture, with a priority on deployment in developing countries and regions such as Africa and Asia.

Maurizio studied physics at the University of California, Berkeley, and subsequently worked in research and technology for nearly 30 years. He previously served as CEO of CompuMed, a telemedicine pioneer, and as CEO of Arrogene. As an inventor, he holds multiple U.S. patents and patent applications in fields related to imaging, image processing, nanobiopolymers, and telecommunications technologies.

Maurizio introduced VCBeat to Global Good’s latest project—the Arktek vaccine cooler. Millions of children living in poverty in resource-limited regions lack access to life-saving vaccines. Arktek is a super-insulated container that can keep vaccines at the appropriate temperature for over a month, even in hot desert environments. This project is being promoted in the Afar region of Ethiopia, while another vaccine cold chain-related project is being carried out in Sierra Leone.

At the WISH Conference, Global Good also unveiled a new handheld device for detecting counterfeit medicines. Based on diffuse reflectance near-infrared spectroscopy, the device allows users to simply place the medication inside for analysis and compare the results against a database via a mobile app, thereby determining the drug’s authenticity. The entire testing process takes only a few seconds.

We asked whether Global Good considers commercial factors, such as return on investment, when selecting projects. Maurizio stated that Global Good’s primary objective is social value rather than other considerations. Backed by Intellectual Ventures (IV) and the Melinda Gates Foundation, Global Good is predominantly public-welfare oriented, focusing on advancing healthcare development and accessibility in impoverished regions and developing countries.

Maurizio also revealed that Global Good currently has some collaborations with Chinese manufacturers and will have more projects in China in the future.

“Globally, 322 million people exhibit symptoms of depression, and 264 million people live with anxiety. The treatment gap is also significant; in some countries, only 1 in 27 individuals can access help, whereas in high-income countries, the proportion is 1 in 5.”

“To expand the scope of treatment, global spending to combat anxiety and depression will reach $184 billion by 2030. Through early intervention, total treatment costs can be reduced, with every $1 invested yielding a return of at least $5.7.”

The aforementioned views are from Paul Farmer, who has served as Chief Executive of Mind, the UK’s leading mental health charity, since May 2006, and concurrently chairs the NHS Mental Health Taskforce. Paul holds an honorary Doctorate of Science from the University of East London, is an Honorary Fellow of St Peter’s College, Oxford, and a Fellow of the Royal College of Psychiatrists, and was appointed Commander of the Order of the British Empire (CBE) in the 2016 New Year Honours.

Paul told VCBeat that his advocacy for combating anxiety and depression stems not only from his academic studies in the field, but also from the fact that his classmates, friends, and family members have suffered from mental health issues, enabling him to empathize deeply with the distress caused by anxiety and depression.

Research by Paul and colleagues indicates that the prevention of anxiety and depression should be implemented at the population level, primarily focusing on three aspects: regarding living conditions, daily needs should be met, including family and social education for young people and improved living conditions for the elderly; in terms of eliminating discrimination and stigma, national policies should be formulated while encouraging individuals with anxiety and depression to speak out about their circumstances; and concerning the work environment, workplace practices that support mental health awareness among employees should be developed, providing an environment that promotes a healthy work-life balance.

Paul also noted that emerging digital technologies have provided significant support in addressing anxiety and depression, including expanding public access to mental health services, strengthening mental health information systems (data collection and monitoring), supporting the delivery of screening, prevention, and treatment, empowering individuals to manage their own mental health needs (prevention and self-care), and connecting people with lived experiences.

“Anxiety and depression should be prioritized as public health concerns. This involves implementing proven, cost-effective, evidence-based interventions; establishing collaborative networks with patient groups, healthcare teams, research institutions, and communities; and leveraging technology and digital solutions,” said Paul.

In fact, in addition to the two interviewees mentioned above, the WISH Conference featured many other distinguished speakers, including Mary Robinson, former President of Ireland; David Miliband, President of the International Rescue Committee and former UK Foreign Secretary; and renowned swimmer Michael Phelps. They delivered compelling addresses focusing on health issues arising from climate change, healthcare conditions in conflict zones, and healthy lifestyles.